Armata Pharmaceuticals, Inc. announced last week that former White House COVID-19 response coordinator Dr. Deborah Birx has been appointed as its new Chief Executive Officer.
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology.
In an interview with Neil Cavuto, Birx admitted that she “knew” that COVID-19 vaccines “were not going to protect against infection” yet she pushed them anyway.
Criminal
Soon to be called noose lady
Quick trial, tall tree, short scarf.
What could possibly Go wrong?